mesalamine has been researched along with Calculosis in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We present two cases of lithiasis in patients treated with mesalazine at high dosage, an adverse effect to betaken into account as a drug lithiasis and which is not even mentioned in the patient information leaflet." | 1.56 | [Mesalazine renal lithiasis.] ( Benavent, G; Frédérique Scheirs, S; Orts, JA; Vílchez, A, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vílchez, A | 1 |
| Orts, JA | 1 |
| Frédérique Scheirs, S | 1 |
| Benavent, G | 1 |
1 other study available for mesalamine and Calculosis
| Article | Year |
|---|---|
[Mesalazine renal lithiasis.]
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calculi; Humans; Kidney; Kidney Calculi; Lithiasis; Mesalam | 2020 |